{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for lopinavir in Display Name (approximate match)
Status:
Other
Class (Stereo):
CHEMICAL (ABSOLUTE)
Conditions:
Lopinavir, (2R) Epimer, a selective HIV protease inhibitor, possesses similar properties with lopinavir.
Status:
Other
Class (Stereo):
CHEMICAL (ABSOLUTE)
Conditions:
Lopinavir, (2R) Epimer, a selective HIV protease inhibitor, possesses similar properties with lopinavir.
There is no information in the scientific papers related to the biological and pharmacological properties of the diastereomer of lopinavir, LOPINAVIR, (2R,4R)-diastereomer.
Status:
Possibly Marketed Outside US
Source:
ANDA078233
(2007)
Source URL:
First approved in 2007
Source:
ANDA078233
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Status:
Possibly Marketed Outside US
Source:
NCT00160849: Phase 4 Interventional Completed HIV Infections
(2004)
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Conditions:
Lopinavir D-Valine Diastereomer, a selective HIV protease inhibitor, possesses similar properties with lopinavir.
Status:
US Approved Rx
(2021)
Source:
ANDA091677
(2021)
Source URL:
First approved in 2000
Source:
KALETRA by ABBVIE
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Lopinavir (ABT-378) is an antiretroviral of the protease inhibitor class. It is used against HIV infections as a fixed-dose combination with another protease inhibitor, ritonavir, under the trade names Kaletra.
